P06: UPDATED RESULTS FROM THE PHASE 1/2 MAJESTEC-1 STUDY OF TECLISTAMAB, A B-CELL MATURATION ANTIGEN X CD3 BISPECIFIC ANTIBODY, IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA

Authors :: R Popat
S Usmani
A Garfall
N van de Donk
H Nahi
J San-Miguel
A Oriol
A Nooka
T Martin
L Rosinol
A Chari
L Karlin
L Benboubker
M Mateos
N Bahlis
P Moreau
B Besemer
J Martínez-López
S Sidana
L Pei
D Trancucci
R Verona
S Girgis
Y Olyslager
M Jaffe
C Uhlar
T Stephenson
R Van Rampelbergh
A Banerjee
J Goldberg
R Kobos
A Krishnan
Source :: HemaSphere. 6:14-14
Publication Year :: 2022
Publisher :: Ovid Technologies (Wolters Kluwer Health), 2022.

Tools